PASG

Passage Bio, Inc. (PASG) SWOT Analysis Analysis (2026)

Invetso Score: 3.6/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Strengths

Score: 4.2 (Moderate)

Negative invested-capital returns indicate weak current capital efficiency, but PASG may still compare favorably if peers are also early-stage or restructuring-heavy.

Weaknesses

Score:

ROIC of -8.9% signals value destruction and materially trails profitable peers, limiting PASG’s structural positioning until returns normalize.

Net debt to EBITDA of 0.74x is manageable, yet leverage still constrains flexibility versus net-cash peers with stronger balance sheets.

Current and quick ratios of 1.22x provide only modest liquidity, leaving less cushion than peers with larger working-capital buffers.

The extremely negative cash-conversion-cycle figure suggests data distortion or unusual working-capital dynamics, but it does not evidence a durable peer advantage.

Opportunities

Score:

If PASG converts working capital more efficiently than peers, it could support faster cash generation and improve relative reinvestment capacity over 2–5 years.

Balance-sheet leverage is not excessive, so incremental earnings improvement could translate into faster equity value recovery than for more indebted peers.

Any operational turnaround that lifts ROIC toward peer norms would have an outsized effect because current returns are deeply negative.

Threats

Score:

Persistently negative ROIC threatens PASG’s competitive standing because peers with positive returns can reinvest more aggressively and compound advantage.

Liquidity is only adequate, so a demand slowdown or margin compression would pressure PASG more than peers with stronger current ratios.

Moderate leverage reduces strategic flexibility versus cleaner balance sheets, increasing vulnerability if financing conditions tighten relative to peers.

Overall Score

Score:

PASG’s structural positioning versus peers is weak because negative capital returns and only adequate liquidity outweigh the absence of severe leverage stress.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Passage Bio, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →